Items without sitelinks

From determinar.ia.br - Determine suas informações

Showing below up to 50 results in range #25,951 to #26,000.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Butyrylcholinesterase deficiency (Q86859)
  2. Metabolic disease involving other neurotransmitter deficiency (Q86858)
  3. Nonunion of fracture, tarsus (Q86857)
  4. Brain stem dysplasia (Q86856)
  5. Agenesis of lung, unilateral (Q86855)
  6. Myotonia of pupil (Q86854)
  7. Agenesis of lung, bilateral (Q86853)
  8. Acute tubulo-interstitial nephritis due to drugs, biological agents or toxins (Q86852)
  9. Acute tubulo-interstitial nephritis due to infectious agent (Q86851)
  10. Nonunion of fracture, toes (Q86850)
  11. Acute streptococcal pharyngitis (Q86849)
  12. Unintentionally struck by projectile from verey pistol or flare (Q86848)
  13. Nonunion of fracture, metatarsus (Q86847)
  14. Acute tubulo-interstitial nephritis associated with immunological disorders (Q86846)
  15. Acute urate nephropathy (Q86845)
  16. Nonunion of fracture, other joints in foot (Q86844)
  17. Unintentionally struck by projectile from other gas, air or spring operated gun discharge (Q86843)
  18. Unintentionally struck by projectile from other weapon (Q86842)
  19. Sequelae of muscle injury of neck (Q86841)
  20. Unintentionally struck by projectile from spring-operated BB gun (Q86840)
  21. Iridoplegia (Q86839)
  22. Unintentionally struck by projectile from paintgun (Q86838)
  23. Hippus (Q86837)
  24. Congenital mydriasis (Q86836)
  25. Neurodegeneration with brain iron accumulation (Q86835)
  26. Secondary iron overload (Q86834)
  27. Myeloid metaplasia (Q86833)
  28. Neonatal haemochromatosis (Q86832)
  29. Myosis (Q86831)
  30. Acquired hemochromatosis (Q86830)
  31. Microcytic anaemia with liver iron overload (Q86829)
  32. Atransferrinaemia (Q86828)
  33. Mydriasis (Q86827)
  34. Intentional self-harm by exposure to or harmful effects of lysergide (Q86826)
  35. Intentional self-harm by exposure to or harmful effects of unspecified psychodysleptics or hallucinogens (Q86825)
  36. Fetus or newborn affected by other forms of placental separation (Q86824)
  37. Intentional self-poisoning by and exposure to narcotics and psychodysleptics or hallucinogens, not elsewhere classified (Q86823)
  38. Intentional self-harm by exposure to or harmful effects of other psychodysleptics or hallucinogens (Q86822)
  39. Splenic primary panhaematopenia (Q86821)
  40. Pneumonia in ascariasis (Q86820)
  41. Intentional self-harm by exposure to or harmful effects of synthetic cannabinoids (Q86819)
  42. Chilblain lupus erythematosus (Q86818)
  43. Intentional self-harm by exposure to or harmful effects of cannabis (Q86817)
  44. Ehlers-Danlos syndrome, rare variants (Q86816)
  45. Endophthalmitis in ascariasis (Q86815)
  46. Distal 17p13.3 deletion (Q86814)
  47. Gamna disease (Q86813)
  48. Fetus or newborn affected by placental dysfunction, not otherwise specified (Q86812)
  49. Brittle diabetes mellitus (Q86811)
  50. 17p12-p11.2 deletion (Q86810)

View ( | ) (20 | 50 | 100 | 250 | 500)